Key facts
- Bipartisan bills are advancing in Congress to require hospitals and insurers to disclose prices.
- Proponents believe increased transparency could lead to significant savings for patients and lower insurance premiums.
- Studies estimate potential savings ranging from $17 billion to $80 billion, or even $120 billion in federal revenue.
- Legislation has advanced through multiple House and Senate committees, indicating broad bipartisan support.
- Hospitals have raised concerns about administrative burdens and the effectiveness of such rules.
- Previous transparency regulations implemented by the Trump administration have had limited impact due to enforcement challenges.
Bipartisan lawmakers are advancing legislation in both the House and Senate aimed at increasing price transparency in the U.S. health care system. The proposed bills would require hospitals and insurers to disclose their prices, a move proponents believe could lead to significant savings for patients and lower insurance premiums.
Various third-party estimates suggest that enhanced price transparency could yield billions of dollars in savings. A University of Minnesota study estimated savings between $17 billion and $80 billion, while a Brown University study projected $120 billion in federal revenue through reduced pre-tax premiums. Despite the varying figures, the bipartisan nature of the effort, bridging senators like Roger Marshall (R-Kan.) and Bernie Sanders (I-Vt.), has fueled optimism.
Senate Health Committee Chair Bill Cassidy (R-La.) expressed confidence that the legislation will pass, potentially as a standalone bill or part of a larger package. The measures are expected to particularly benefit the over 40 million Americans with high-deductible health plans, making it easier for them to compare treatment costs. Even those with traditional insurance could see benefits if transparency helps restrain premium increases.
Both Republicans and Democrats see political advantages in pursuing health care affordability. Republicans aim to demonstrate concern for costs following votes on Medicaid spending and Obamacare subsidies, while Democrats seek to reinforce their role as advocates for working people. The bipartisan consensus on price transparency stands in contrast to broader partisan disagreements on health care policy.
Key legislative efforts include the Patients Deserve Price Tags Act in the Senate, sponsored by Sen. Marshall, and the Lower Costs, More Transparency Act in the House, advanced by Rep. Brett Guthrie (R-Ky.) and Rep. Frank Pallone (D-N.J.). The House bill includes fines for hospitals failing to reveal price lists. Hospitals have voiced concerns about increased administrative burdens and argue that transparency alone does not solve underlying affordability issues.
Support for transparency measures comes from a diverse coalition including progressive advocacy groups, large employers, and conservative think tanks. Additional transparency bills have been approved by the House Ways and Means Committee and the Education and Workforce Committee. Senators Marsha Blackburn (R-Tenn.) and Mark Warner (D-Va.) have also introduced a bill targeting Medicare Advantage plans.
Previous attempts to enact significant health care price transparency, notably in December 2024, faced challenges, including criticism from Elon Musk regarding extraneous provisions. While Republicans later removed contentious elements, the focus on transparency was sidelined. It is now re-emerging as a key bipartisan initiative, with lawmakers aiming to codify and strengthen existing regulations, making data more comprehensible and enforceable.